Last Posted: Sep 11, 2020
- Evaluation of CDC's Hemophilia Surveillance Program - Universal Data Collection (1998-2011) and Community Counts (2011-2019), United States.
Schieve Laura A et al. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) 2020 Sep (5) 1-18 - BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Konkle Barbara A et al. The New England journal of medicine 2020 Sep (11) 1018-1027 - Prevalence of FVIII Inhibitors Among Children with Hemophilia A: Experience at the Jordanian Royal Medical Services.
Oudat Raida et al. Medical archives (Sarajevo, Bosnia and Herzegovina) 2020 Jun 74(3) 187-190 - Beliefs and Values About Gene Therapy and In-Utero Gene Editing in Patients with Hemophilia and Their Relatives.
Vasquez-Loarte Tania C et al. The patient 2020 Aug - Gene therapy for hemophilia: anticipating the unexpected.
Pierce Glenn F et al. Blood advances 2020 Aug 4(15) 3788 - CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige Satoshi et al. International journal of hematology 2020 Feb 111(2) 225-233 - How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease.
Leebeek Frank W G et al. Blood 2020 Aug - Advances in Alpha-1 Antitrypsin Gene Therapy.
Lorincz Reka et al. American journal of respiratory cell and molecular biology 2020 Jul - A Practical Guide to the Management of the Fetus and Newborn With Hemophilia.
Moorehead Paul C et al. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2018 Dec 24(9_suppl) 29S-41S - What does the 'Cochrane database of systematic reviews' tell us about hemophilia?
Rodriguez-Merchan Emerito-Carlos et al. Expert review of hematology 2019 12(11) 919-922
.png)
No hay comentarios:
Publicar un comentario